Search results for "Press"

showing 10 items of 15058 documents

P01-92 - Early Changes are Associated with late Changes of BDNF Serum Levels in Inpatients with Major Depression During Short-term Antidepressant Tre…

2010

ObjectivesMean BDNF serum concentration is lower in patients with major depression (MD) as compared to healthy controls. BDNF increases during the course of antidepressant treatment. This increase has been associated with symptom amelioration. The aim of this study was to analyse the relation between early and late BDNF changes during antidepressant treatment.MethodsForty-six patients with MD according to DSM-IV were included for this study. Patients were treated as clinically indicated. Depression severity was assessed by HAMD-17 by trained raters from baseline to week 6 in weekly intervals. Serum at each visit (baseline, V1-V6) was obtained from whole blood after centrifugation with 1.000…

medicine.medical_specialtySerum concentrationPsychiatry and Mental healthEndocrinologynervous systemInternal medicinemedicineAntidepressantIn patientsense organsskin and connective tissue diseasesPsychiatryPsychologyDepression (differential diagnoses)Whole bloodEuropean Psychiatry
researchProduct

Effects of Sulpiride Treatment on the Hypothalamic Supraoptic and Paraventricular Nuclei

2009

medicine.medical_specialtySettore BIO/16 - Anatomia Umanabusiness.industrymedia_common.quotation_subjectGeneral MedicinePharmacologySulpiridehypothalamic supraoptic nucleushypothalamic paraventricular nucleusmenstrual cyclePharmacotherapyEndocrinologyHypothalamusInternal medicinePharmacodynamicsmedicineSulpiridebusinessMenstrual cycleDepression (differential diagnoses)media_commonmedicine.drugResearch Journal of Biological Sciences
researchProduct

Electrocardiography for Assessment of Hypertensive Heart Disease: A New Role for an Old Tool

2016

Left ventricular (LV) hypertrophy (LVH), detected either by electrocardiography (ECG) or echocardiography (ECHO), has long been recognized as a powerful predictor of serious cardiovascular (CV) sequelae. A very large and highly consistent body of evidence indicates that LVH is not only an adaptation to increased hemodynamic load in hypertension, but is also independently associated with an enhanced risk for myocardial infarction, cardiac sudden death, congestive heart failure, and stroke in the general population, as well as in patients with systemic hypertension, coronary heart disease, chronic kidney disease, and atrial fibrillation. Intriguingly, the cumulative incidence of cardiovascula…

medicine.medical_specialtySettore MED/09 - Medicina InternaCardiology and Cardiovascular Medicine; Internal Medicine; Endocrinology Diabetes and MetabolismEndocrinology Diabetes and MetabolismPopulation030204 cardiovascular system & hematologyCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicineInternal MedicineMedicinecardiovascular diseases030212 general & internal medicineMyocardial infarctioneducationSettore MED/14 - Nefrologiaeducation.field_of_studymedicine.diagnostic_testbusiness.industryAtrial fibrillationmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareHypertensive heart diseaseBlood pressureHeart failureCardiologyPhysical therapyCardiology and Cardiovascular MedicinebusinessElectrocardiography
researchProduct

Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease

2014

Many placebo controlled trials and meta-analyses evaluated the efficacy of different drugs for the treatment of inflammatory bowel disease (IBD), including immunosuppressants and biologics. Their use is indicated in moderate to severe disease in non responders to corticosteroids and in steroid-dependent patients, as induction and maintainance treatment. Infliximab, as well as cyclosporine, is considered a second line therapy in the case of severe ulcerative colitis, or non-responders to intravenous corticosteroids. An adequate dosage and duration of therapy with thiopurines should be reached before evaluating their efficacy. Methotrexate is a valid option in patients with Crohn’s disease bu…

medicine.medical_specialtySettore MED/09 - Medicina InternaCombination therapyInflammatory bowel diseaseGastroenterologyimmunosuppresantbiologicsinflammatory bowel diseaseCrohn DiseaseGastrointestinal AgentsRisk FactorsInternal medicinemedicineimmunomodulators.optimization. treatmentHumansTopic HighlightBiological ProductsGastrointestinal agentCrohn's diseaseThiopurine methyltransferasebiologybusiness.industryGastroenterologyGeneral Medicinemedicine.diseaseUlcerative colitisTacrolimusInfliximabSurgeryTreatment Outcomebiology.proteinColitis UlcerativeDrug Therapy CombinationbusinessImmunosuppressive Agentsmedicine.drug
researchProduct

Magnesium and hypertension in old age

2021

Hypertension is a complex condition in which various actors and mechanisms combine, resulting in cardiovascular and cerebrovascular complications that today represent the most frequent causes of mortality, morbidity, disability, and health expenses worldwide. In the last decades, there has been an exceptional amount of experimental, epidemiological, and clinical studies confirming a close relationship between magnesium deficit and high blood pressure. Multiple mechanisms may help to explain the bulk of evidence supporting a protective effect of magnesium against hypertension and its complications. Hypertension increases sharply with advancing age, hence older persons are those most affected…

medicine.medical_specialtySettore MED/09 - Medicina InternaMagnesium supplementationchemistry.chemical_elementBlood Pressurelcsh:TX341-641Review030204 cardiovascular system & hematologyHypertension riskAging Cardiovascular disease03 medical and health sciences0302 clinical medicineInsulin resistancecardiovascular diseaseMagnesium deficiency (medicine)EpidemiologymedicineHumansMagnesium030212 general & internal medicineMicronutrientsIonIntensive care medicineAgedAged 80 and overNutrition and Dieteticsbusiness.industryMagnesiumagingInsulin resistanceFeeding Behaviormedicine.diseaseDietBlood pressurechemistryClose relationshipDietary SupplementsHypertensionionsbusinessMagnesium Deficiencylcsh:Nutrition. Foods and food supplyFood ScienceSupplement
researchProduct

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospect…

2014

Summary Background Body-mass index (BMI) and diabetes have increased worldwide, whereas global average blood pressure and cholesterol have decreased or remained unchanged in the past three decades. We quantified how much of the effects of BMI on coronary heart disease and stroke are mediated through blood pressure, cholesterol, and glucose, and how much is independent of these factors. Methods We pooled data from 97 prospective cohort studies that collectively enrolled 1·8 million participants between 1948 and 2005, and that included 57 161 coronary heart disease and 31 093 stroke events. For each cohort we excluded participants who were younger than 18 years, had a BMI of lower than 20 kg/…

medicine.medical_specialtySettore MED/09 - Medicina InternaNutrition and Diseasenoncommunicable diseasesbariatric surgeryscientific statementcardiovascular-diseaseCoronary DiseaseOverweightsystematic analysisBody Mass Indexblood-pressureInternal medicineDiabetes mellitusVoeding en ZiektemedicineHumansProspective cohort studyrisk-factorsStrokeVLAGHuman Nutrition & HealthGlobal NutritionWereldvoedingFramingham Risk Scorebusiness.industryHumane Voeding & GezondheidArticlesGeneral MedicineOverweightmedicine.diseaseObesityStrokeBlood pressurerandomized-trialsPhysical therapyCardiologyall-cause mortalitymedicine.symptombusinessBody mass indexbody-mass index obesity coronary heart disease strokeweight-loss
researchProduct

Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria

2017

The kidney is one of the major target organs of hypertension. Kidney damage represents a frequent event in the course of hypertension and arterial hypertension is one of the leading causes of end-stage renal disease (ESRD). ESRD has long been recognized as a strong predictor of cardiovascular (CV) morbidity and mortality. However, over the past 20 years a large and consistent body of evidence has been produced suggesting that CV risk progressively increases as the estimated glomerular filtration rate (eGFR) declines and is already significantly elevated even in the earliest stages of renal damage. Data was supported by the very large collaborative metaanalysis of the Chronic Kidney Disease …

medicine.medical_specialtySettore MED/09 - Medicina InternaRenal function030204 cardiovascular system & hematologyAsymptomatic03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicine030212 general & internal medicineSubclinical infectionSettore MED/14 - NefrologiaKidneyCreatinineProteinuriabusiness.industryArterial hypertension • Blood pressure • Glomerular filtration rate • Microalbuminuria • Proteinuria • Subclinical renal disease • Early kidney injury • Target organ damage • Cardiovascular disease • Cardiovascular risk assessmentmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structureEndocrinologychemistryCardiologyMicroalbuminuriamedicine.symptombusinessKidney disease
researchProduct

Ten physiological commandments for severe head injury

2020

Advances in multiparametric brain monitoring have allowed us to deepen our knowledge of the physiopathology of head injury and how it can be treated using the therapies available today. It is essential to understand and interpret a series of basic physiological and physiopathological principles that, on the one hand, provide an adequate metabolic environment to prevent worsening of the primary brain injury and favour its recovery, and on the other hand, allow therapeutic resources to be individually adapted to the specific needs of the patient. Based on these notions, this article presents a decalogue of the physiological objectives to be achieved in brain injury, together with a series of …

medicine.medical_specialtySevere head injuryIntracranial Pressurebusiness.industryHead injuryArterial oxygenBrainCerebral hypoxia030208 emergency & critical care medicineGeneral MedicineBrain monitoringmedicine.diseaseNeuroprotectionAbdominal pressureOxygen03 medical and health sciences0302 clinical medicineBrain InjuriesmedicineHumansHypoxia BrainIntensive care medicinebusiness030217 neurology & neurosurgeryIntracranial pressureRevista Española de Anestesiología y Reanimación (English Edition)
researchProduct

Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia

2011

Jorge Mauriño1, Julio Sanjúan2, Josep Maria Haro3, Teresa Díez1, Javier Ballesteros41AstraZeneca Medical Department, Madrid, Spain; 2Department of Psychiatry, University of Valencia, CIBERSAM, Valencia, Spain; 3Parc Sanitari Sant Joan de Deu, CIBERSAM, Sant Boi de Llobregat, Spain; 4Department of Neuroscience-Psychiatry, University of the Basque Country, UPV/EHU, CIBERSAM, Leioa, SpainObjective: The subjective experience of psychotic patients toward treatment is a key factor in medication adherence, quality of life, and clinical outcome. The aim of this study was to assess the subjective well-being in patients with schizophrenia and to examine its relationsh…

medicine.medical_specialtyShort ReportPHARMACOLOGY TOXICOLOGY AND PHARMACEUTICSMedicine (miscellaneous)patient-reported outcomeCorrelationdepressive symptomsSOCIAL SCIENCESQuality of lifeInternal medicineHEALTH POLICY AND SERVICESMedicineSubjective well-beingPsychiatryPharmacology Toxicology and Pharmaceutics (miscellaneous)Depressive symptomsRank correlationMEDICINEbusiness.industryHealth PolicyArea under the curvemedicine.diseaseschizophreniapatient reported outcomesubjective well beingsubjective well-beingPatient Preference and AdherenceSchizophreniaPatient-reported outcomebusinessSocial Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

Safety and tolerability of β3-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental s…

2016

We have reviewed the safety and tolerability of β3-adrenoceptor agonists, specifically mirabegron and solabegron, a newly emerging drug class for the treatment of the overactive bladder syndrome. We discuss them mechanistically in the context of expression and other preclinical data.Based on a systematic PubMed search, incidence of overall adverse events, hypertension, dry mouth, and constipation are comparable between mirabegron or solabegron and placebo. Hypertension is the most frequently observed adverse event, but has a similar incidence with mirabegron and placebo. Nevertheless, severe uncontrolled hypertension has become a contraindication for use of mirabegron based on observation o…

medicine.medical_specialtySide effect030232 urology & nephrologyUrologyContext (language use)Adrenergic beta-3 Receptor AgonistsBenzoates03 medical and health sciences0302 clinical medicineSolabegronmedicineAnimalsHumansPharmacology (medical)Adverse effectAniline Compoundsbusiness.industryUrinary Bladder OveractiveGene Expression ProfilingBiphenyl CompoundsGeneral MedicineBiphenyl compoundThiazolesTolerability030220 oncology & carcinogenesisAnesthesiaReceptors Adrenergic beta-3AcetanilidesTolterodinebusinessMirabegronmedicine.drugExpert opinion on drug safety
researchProduct